Lung cancer screening

Lung cancer screening refers to the process of detecting lung cancer at an early stage, before symptoms appear. This is typically done through the use of low-dose computed tomography (LDCT) scans, which can identify small nodules or other abnormalities in the lungs that may be indicative of cancer.

Overview

Lung cancer is the leading cause of cancer death worldwide. Early detection through screening can significantly improve survival rates, as treatment is often more effective when the disease is caught early. However, lung cancer screening is not without risks, and it is important to weigh these against the potential benefits.

Screening methods

The primary method of lung cancer screening is low-dose computed tomography (LDCT). This type of scan uses a small amount of radiation to create detailed images of the lungs. LDCT scans are more effective at detecting lung cancer than traditional x-rays, and are currently the only recommended screening method for lung cancer.

Other methods, such as sputum cytology (examining mucus under a microscope) or molecular markers, are currently being researched but are not yet recommended for routine screening.

Who should be screened

Lung cancer screening is recommended for individuals who are at high risk of developing lung cancer. This includes:

• People aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years
• People with a family history of lung cancer
• People with certain occupational exposures, such as asbestos

Risks and benefits

While lung cancer screening can detect cancer early and potentially save lives, it also carries risks. These include:

• False positives: LDCT scans can detect small nodules that are not cancerous, leading to unnecessary follow-up tests and procedures.
• Overdiagnosis: Some cancers detected through screening may never cause symptoms or lead to death, leading to unnecessary treatment.
• Radiation exposure: While the amount of radiation used in LDCT scans is small, repeated scans can lead to a small increase in the risk of developing other cancers.

Conclusion

Lung cancer screening is a valuable tool in the fight against lung cancer, but it is not without risks. It is important for individuals to discuss these risks and benefits with their healthcare provider to make an informed decision about screening.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian